Highbridge Capital Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-254,265
| Closed | -$674K | – | 309 |
|
|
2025
Q3 | $674K | Hold |
254,265
| – | – | 0.03% | 113 |
|
|
2025
Q2 | $250K | Hold |
254,265
| – | – | 0.01% | 141 |
|
|
2025
Q1 | $366K | Hold |
254,265
| – | – | 0.02% | 104 |
|
|
2024
Q4 | $559K | Hold |
254,265
| – | – | 0.02% | 136 |
|
|
2024
Q3 | $420K | Hold |
254,265
| – | – | 0.02% | 137 |
|
|
2024
Q2 | $564K | Buy |
+254,265
| New | +$598K | 0.02% | 112 |
|
|
2024
Q1 | – | Sell |
-221,722
| Closed | -$663K | – | 355 |
|
|
2023
Q4 | $663K | Sell |
221,722
-32,543
| -13% | -$42.2K | 0.04% | 116 |
|
|
2023
Q3 | $249K | Hold |
254,265
| – | – | 0.01% | 167 |
|
|
2023
Q2 | $353K | Hold |
254,265
| – | – | 0.02% | 153 |
|
|
2023
Q1 | $404K | Hold |
254,265
| – | – | 0.02% | 172 |
|
|
2022
Q4 | $1.58M | Sell |
254,265
-165,653
| -39% | -$1.18M | 0.05% | 224 |
|
|
2022
Q3 | $2.81M | Hold |
419,918
| – | – | 0.04% | 303 |
|
|
2022
Q2 | $2.67M | Hold |
419,918
| – | – | 0.07% | 311 |
|
|
2022
Q1 | $1.95M | Buy |
419,918
+74,323
| +22% | +$319K | 0.05% | 309 |
|
|
2021
Q4 | $1.73M | Buy |
+345,595
| New | +$2.77M | 0.04% | 314 |
|
|
2017
Q2 | – | Sell |
-31,064
| Closed | -$1.1M | – | 1365 |
|
|
2017
Q1 | $1.1M | Buy |
+31,064
| New | +$711K | 0.02% | 589 |
|
|
2016
Q4 | – | Sell |
-11,976
| Closed | -$165K | – | 1366 |
|
|
2016
Q3 | $165K | Buy |
+11,976
| New | +$136K | ﹤0.01% | 1211 |
|
|
2015
Q4 | – | Sell |
-236,669
| Closed | -$5.58M | – | 1592 |
|
|
2015
Q3 | $5.58M | Buy |
+236,669
| New | +$14.9M | 0.11% | 281 |
|
|
2015
Q2 | – | Sell |
-94,527
| Closed | -$8.75M | – | 1512 |
|
|
2015
Q1 | $8.75M | Buy |
+94,527
| New | +$6.1M | 0.14% | 222 |
|
Other funds holding ESPR
TSC
WA
O
